presented

Business

New Prospective, Multicenter Study Presented at SMR Demonstrates Castle Biosciences’ DecisionDx ®-Melanoma Test Provides Significant Risk Prediction for Patients with Cutaneous Melanoma, Adding Valu

October 9, 2024
7
New Prospective, Multicenter Study Presented at SMR Demonstrates Castle Biosciences’ DecisionDx ®-Melanoma Test Provides Significant Risk Prediction for Patients with Cutaneous Melanoma, Adding Valu

FRIENDSWOOD, Texas–(BUSINESS WIRE)–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced…

Read More »
Business

Medincell’s Partner Teva Presented New Efficacy, Safety, and Tolerability Data from Pivotal Phase 3 of Olanzapine LAI for Adult Patients Diagnosed with Schizophrenia

September 23, 2024
10

MONTPELLIER, France–(BUSINESS WIRE)–Teva presented at ECNP 2024 new positive efficacy, safety, and tolerability results for Phase 3 SOLARIS trial evaluating…

Read More »
Politics

THE OFFICIALS Presented by TIME Studios

September 19, 2024
10

Ideas September 19, 2024 7:04 AM EDT US election officials in rural and urban jurisdictions of four battleground states hold…

Read More »
Business

Two Ivonescimab (PD-1/VEGF) Results including Phase 3 Monotherapy versus Pembrolizumab Monotherapy in First-Line Treatment for PD-L1 Positive NSCLC to Be Presented at WCLC 2024

August 11, 2024
11

First Release of Phase III Head-to-Head Clinical Study Data of Ivonescimab versus Pembrolizumab in NSCLC Ivonescimab Is the First Drug…

Read More »
Back to top button